Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Presented for research literature review only Anderson EI et al
Temperature fluctuations degrade the compound quickly
That distinction is part of why it attracted research interest, and part of why the story is more complicated than vendor pages suggest
FDA Regulatory Status (2026 Update) GHK-Cu is not FDA-approved for any medical indication
Crucially, the weight loss trajectory at 26 weeks had not plateaued suggesting that longer treatment duration would produce further reductions
PCAC member Elizabeth Rebello, a professor in the Department of Anesthesiology and Perioperative Medicine at the University of Texas MD Anderson Cancer Center, cited the "lack of efficacy data and randomized controlled trials" as her basis for her no vote
US$ 22.80
US$ 23.40
US$ 27.88
US$ 25.57
US$ 26.76
